$4550
$3640
The 3D printed drugs marketwas valued at US$ 28.52million in 2019 and is expected to grow at a CAGR of 9.1% from 2020to 2027 to reach US$57.03million by 2027.
3D printed drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact. The main idea behind 3D printing drugs is to design and develop medicines that are suited to an individual's needs.The global 3D printed drugs market is driven by factors such asincreasing adoption of personalized drugs. Additionally, growing research and development activities,coupled with increasing prevalence of dysphagia,is also anticipated to drive the 3D market growth during the forecast period. However, the usage of 3D printing to develop illegal drugs restrains the growth of the market. The developing healthcare infrastructure and increasing awareness regarding 3D printing in pharmaceuticals generate lucrative opportunities for the growth of the market.
Lucrative Regional 3D Printed Drugs Markets
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Adoption of Personalized Drugs
Personalized medicine is a growing area of treatment that relies on specific drug delivery and dosing. As per a study published by PMC, personalized medicines accounted for only 5% of the new FDA approved molecular entities in 2005; whereas, in 2016, they accounted for more than 25%. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to be personalized medicines. Moreover, biopharmaceutical companies nearly doubled their R&D investment in personalized drugs over the past five years, and expect to increase their investment by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the number of personalized medicines in development over the coming five years.
3D printing offers the possibility of creating a personalized medicine system through automated control over drug dose and is suitable for both low and high drug concentrations. These advantages allow drug companies to not only boost efficacy and adherence, but also contribute to their brand longevity by expanding and capturing market share with other dosage forms. Through this breakthrough method of manufacturing and its fast-melt capabilities, there is an ability to overcome several obstacles, thereby contributing to better patient outcomes in the solid dose market. For instance, FabRx Ltd. completed the world’s first in-human clinical study using their proprietary Printlets technology, which relies on personalized 3D printed dosage forms to treat children with a rare metabolic disease. Additionally, the same company launched the first pharmaceutical 3D printer, M3DIMAKER, for the manufacture of personalized medicines in April 2020. Hence, there is a need for new manufacturing systems to prepare personalized medicines, and this potential application of 3D printing for rare diseases is countless. It could help make the medication safer and more attractive to children, thereby propelling the growth of the 3D printed drugs market.
Dosage Form-BasedInsights
Based on dosage form, the 3D printed drugs market is segmented into tablets, capsules, multi drug implants, nanoparticles, solutions, and other dosage forms. In 2019, thetabletssegment held the largest share of the market, and it is further expected to register the highest CAGR in the market during the forecast period. At present, 3D printed drugs are available only in the form of tablets in the market. However, the other dosage forms are likely to be commercialized in the coming years.
3D Printed Drugs Market, by Dosage Form– 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Technology-BasedInsights
Based on technology, the 3D printed drugs market is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, stereolithography (SLA), and semi solid extrusion (SSE). The zip dose technology segmentheld the largest share of the market; moreover, it is expected to register the highest CAGR during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
3D Printed Drugs Market: Strategic Insights
Market Size Value in US$ 28.52 Million in 2019 Market Size Value by US$ 57.03Million by 2027 Growth rate CAGR of 9.1% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
3D Printed Drugs Market: Strategic Insights

Market Size Value in | US$ 28.52 Million in 2019 |
Market Size Value by | US$ 57.03Million by 2027 |
Growth rate | CAGR of 9.1% from 2020-2027 |
Forecast Period | 2020-2027 |
Base Year | 2020 |

Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Product launches and FDA approvalsis a commonly adopted strategy by companies to expand their footprint worldwide and meet the growing demand as the strategy allows them to expand their product portfolios.
The 3D printed drugs marketplayers also adopt the strategy ofcollaborations, which enables them enlarge their global customer base,alongside helping them maintain their brand names.
3D Printed Drugs Market – By Dosage Forms
- Tablets
- Capsules
- Multi Drug Implants
- Nanoparticles
- Solutions
- Others
3D Printed Drugs Market – By Technology
- Inkjet Printing
- Direct Write
- Zip Dose
- Thermal Inkjet Printing
- Fused Deposition Modeling
- Powder Bed Printing
- Stereolithography (SLA)
- Semi Solid Extrusion (SSE)
3D Printed DrugsMarket– By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- APRECIA PHARMACEUTICALS, LLC
- FabRx LTD
- Cycle Pharmaceuticals
- GLAXOSMITHKLINE PLC.
- ASTRAZENECA
- Tvasta
- Merck KGGA
- Terumo Corporation

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Dosage Forms ; Technology , and Geography

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Frequently Asked Questions
3D Printed Drugs are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary porous structures that readily disperse in the mouth, because of which these high-dose medicines need not to be swallowed intact.
Increasing awareness of benefits offered by 3D printed drugs and growing emphasis on personalized medicines
Aprecia Pharmaceuticals, LLC and FabRx LTD are the major players in the market.
The List of Companies - 3D Printed Drugs Market
- APRECIA PHARMACEUTICALS, LLC
- FabRx LTD
- Cycle Pharmaceuticals
- GLAXOSMITHKLINE PLC.
- ASTRAZENECA
- Tvasta
- Merck KGGA
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports

Apr 2020
Bovine Diagnostics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products), Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Types], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography

Apr 2020
Endoscopy Procedures Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Procedures [Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Submucosal Dissection (ESD), Peroral Endoscopic Myotomy (POEM), Endoscopic Ultrasound (EUS), Interventional Pulmonology and Laparoscopy, Arthroscopy and Bronchoscopy, Colonoscopy and Colposcopy, Proctoscopy and Thoracoscopy, and Others], Offering [Endoscopes, ERCP Accessories, Head positioner and Endotherapy Injection Needles, Sampling Device and Device Clip and Electrosurgical Knife, Endoscopic Ultrasound (EUS) Guided Devices, Guidewire, Forceps, Snare, Irrigation/Insufflation tubing systems, Probes, Hemostasis Clip, Polyp Traps, Single-Use Valves , Trocar sleeves and Tissue Scissors and Cutters, Retrieval Devices, and Others (Kits/Stents/Energy Devices/ Transport pad/Cleaning Brush/OT Lights, etc.)], Product Type (Disposable and Reusable), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Apr 2020
Dental Bone Graft Substitutes and Barrier Membrane Market
Forecast to 2030 - Global Analysis by Product [Dental Bone Graft Substitutes (Allograft, Xenograft, Synthetic Bone Graft, Autografts, Alloplasts, Demineralized Bone Matrix (DBM-Allograft, and Others) and Dental Barrier Membrane (Resorbable Membrane and Non-Resorbable Membrane)], Procedure [Guided Bone Regeneration Procedures (GBR), Guided Tissue Regeneration Procedures (GTR), Sinus-Lift Procedures and Ridge-Split Procedures, Alveolar Ridge Preservation (ARP), Block-Graft Procedures, Periodontal Regeneration Procedures, Socket Preservation, and Others], End User (Hospitals, Dental Clinics, and Others), and Geography

Apr 2020
Lung Cancer Screening Market
Size and Forecast to 2030 - Global Analysis by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

Apr 2020
Digital Thoracic Drainage Devices Market
Forecast to 2030 - Global Analysis by Product Type (Single Chamber and Multiple Chambers), Application (Cardiac Surgeries, Thoracic and Pulmonary Surgery, Oncology and Trauma, Infectious Diseases, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography

Apr 2020
Cardiopulmonary Oxygenator Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Bubble Oxygenator and Membrane Oxygenator), Application (Cardiac and Respiratory), Type (Disposable Cardiopulmonary Oxygenator and Reusable Cardiopulmonary Oxygenator), Age Group (Adults, Pediatric, and Neonates), and End Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Others)

Apr 2020
Gastric Cancer Diagnostic Procedure Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Healthcare Provider (Diagnostic Laboratories, Hospitals, Cancer Research Institutes, Oncology Specialty Clinics, and Others), Symptom Type (Symptomatic and Asymptomatic), Body Fluid (Blood, Urine, Saliva, Stomach Wash/Gastric Juice, Tissue, and Others), Procedure (Endoscopic Procedures, Biopsy & Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics & Immunoassays, and Others), Offering [Instruments, Reagents & Consumables (Including Kits), and Services], and Disease Indication (Early Gastric Cancer and Gastric Cancer Advanced Types)